Wound Care Market Size, Share & Trends Analysis By Product (Advanced, Traditional), By Application (Chronic Wounds), By End-use (Hospitals, Nursing Homes), By Mode Of Purchase, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Wound Care Market Size, Share & Trends Analysis By Product (Advanced, Traditional), By Application (Chronic Wounds), By End-use (Hospitals, Nursing Homes), By Mode Of Purchase, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030


Wound Care Market Growth & Trends

The global wound care market is anticipated to reach USD 29.57 billion by 2030, growing at a CAGR of 4.17% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing number of surgical cases, a rapidly aging population, as well as a rising number of diabetic patients, are among the major factors driving this market’s growth. For instance, according to Ageing Asia, as of 2019, more than 139 million people, i.e., about 10% of India’s total population, were over 60. This is expected to increase up to 19.5% in 2050. The geriatric population is more susceptible to wounds, and thus, increasing the number of elder populations, the wound care market is anticipated to propel during the forecast period.

The wound care market has seen significant technological advancements in recent years, leading to the development of new and innovative products for treating various types of wounds. Growth factors are naturally occurring proteins that stimulate cell growth and division. These proteins can be used in wound care to promote healing and tissue regeneration. For example, platelet-derived growth factor (PDGF) is effective in promoting the healing of chronic wounds. 3D printing technology has revolutionized the production of custom-made wound care products, such as prosthetic limbs, orthotics, and wound dressings.

In addition, many leading manufacturers are undergoing strategic initiatives such as product launches, partnerships, and geographic expansion, which may help them capitalize on the increasing demand for wound care products during the forecast period. For instance, Human Biosciences planned on launching two new wound care products in the Indian market. The launch of these products in the Indian market is expected to help the company capture the post-pandemic wound care market in India. Thus, similar initiatives by other market players are anticipated to boost the wound care market post-pandemic.

Wound Care Market Report Highlights
  • Based on product, advanced wound dressing dominated the wound care market with a share of 34.9% in 2023, owing to the advantages offered by these dressings over traditional
  • Based on application, the chronic wound segment will likely dominate the wound care market with a market share of 59.9% in 2023, owing to increased diabetic foot ulcers and pressure ulcers worldwide
  • Based on end-use, the hospital segment dominated the wound care market, owing to the increasing number of surgical site infections among hospital patients. On the other hand, the home healthcare segment is anticipated to witness the fastest growth in the forecast period
  • Based on the mode of purchase, the prescribed segment dominated the wound care market, with a share of 62.8% in 2023
  • Based on the distribution channel, the institutional sales segment dominated the market. However, the retail sales segment is anticipated to witness the fastest growth, with a CAGR of 4.6% over the forecast period
  • North America dominated the wound care market with the highest revenue share of 45.5% in 2023 owing to the increasing number of surgical procedures and technological advancements
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Wound Care Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Mode of purchase
1.1.5. Distribution channel
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Wound Care Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights
Chapter 3. Wound Care Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. User Perspective Analysis
3.3. Covid-19 Impact Analysis
3.4. Trend of Self-medication
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.5.1.2. Rising incidence of burn injuries
3.5.1.3. Introduction of innovative and advanced wound products
3.5.1.4. Rising geriatric population
3.5.1.5. Increasing number of ambulatory surgical centers (ASCs)
3.5.1.6. Increasing number of road accidents
3.5.1.7. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions
3.5.2. Market restraint analysis
3.5.2.1. Stringent manufacturing policies
3.5.2.2. High cost of advanced wound care products and chronic wound treatments
3.5.2.3. Delayed diagnosis and lower treatment rates in emerging nations
3.5.3. Market opportunity analysis
3.5.3.1. Improvements in public and private hospital infrastructure
3.5.3.2. Growth potential in emerging economies in wound care market
3.5.3.3. Leveraging digital platforms and telemedicine in wound care market
3.5.4. Market challenge analysis
3.5.4.1. Growing instances of product recalls
3.5.4.2. Lack of awareness about proper wound care practices and available treatment options
3.6. U.S. Wound Care Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier power
3.6.1.2. Buyer power
3.6.1.3. Substitution threat
3.6.1.4. Threat of new entrant
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic landscape
3.6.2.3. Social landscape
3.6.2.4. Technological landscape
3.6.2.5. Environmental landscape
3.6.2.6. Legal landscape
Chapter 4. Wound Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Advanced wound dressing
4.1.2. Surgical wound care
4.1.3. Traditional wound care
4.1.4. Wound therapy devices
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Advanced wound dressing
4.5.1.1. Advanced wound dressing market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.4. Film dressings
4.5.1.4.1. Film dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.7. Collagen dressings
4.4.1.7.1. Collagen dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.2. Surgical wound care
4.5.2.1. Surgical wound care market estimates and forecast 2018 - 2030 (USD Million)
4.5.2.2. Sutures & staples
4.5.2.2.1. Sutures & staples market estimates and forecast 2018 - 2030 (USD Million)
4.5.2.3. Tissue adhesives & sealants
4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2018 - 2030 (USD Million)
4.5.2.4. Anti-infective dressing
4.5.2.4.1. Anti-infective dressing market estimates and forecast 2018 - 2030 (USD Million)
4.5.3. Traditional wound care
4.5.3.1. Traditional wound care market estimates and forecast 2018 - 2030s, (USD Million)
4.5.3.2. Medical tapes
4.5.3.2.1. Medical tapes market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.3. Cotton
4.5.3.3.1. Cotton market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.4. Bandages
4.5.3.4.1. Bandages market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.5. Gauzes
4.5.3.5.1. Gauzes market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.6. Sponges
4.5.3.6.1. Sponges market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.7. Cleansing agents
4.5.3.7.1. Cleansing agents market estimates and forecast 2018 - 2030 (USD Million)
4.5.4. Wound therapy devices
4.5.4.1. Wound therapy devices market estimates and forecast 2018 - 2030s, (USD Million)
4.5.4.2. Negative pressure wound therapy
4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.3. Oxygen and hyperbaric oxygen equipment
4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.4. Electric stimulation devices
4.5.4.4.1. Electric stimulation devices market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.5. Pressure relief devices
4.5.4.5.1. Pressure relief devices market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.6. Others
4.5.4.6.1. Others market estimates and forecast 2018 - 2030 (USD Million)
Chapter 5. Wound Care Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Acute Wounds
5.5.1.1. Acute wounds market estimates and forecast 2018 - 2030 (USD Million)
5.5.1.2. Surgical & traumatic wounds
5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 - 2030 (USD Million)
5.5.1.3. Burns
5.5.1.3.1. Burns market estimates and forecast 2018 - 2030 (USD Million)
5.5.2. Chronic Wounds
5.5.2.1. Chronic wounds market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.2. Diabetic foot ulcers
5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.3. Pressure ulcers
5.5.2.3.1. Pressure ulcers market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.4. Venous leg ulcers
5.5.2.4.1. Venous leg ulcers market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.5. Others chronic wounds
5.5.2.5.1. Others chronic wounds market estimates and forecast 2018 - 2030 (USD Million)
Chapter 6. Wound Care Devices: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Specialty clinics
6.1.3. Home healthcare
6.1.4. Physician’s office
6.1.5. Nursing homes
6.1.6. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 - 2030 (USD Million)
6.5.2. Specialty clinics
6.5.2.1. Specialty clinics centers market estimates and forecast 2018 - 2030 (USD Million)
6.5.3. Home healthcare
6.5.3.1. Home healthcare market estimates and forecast 2018 - 2030 (USD Million)
6.5.4. Physician’s office
6.5.4.1. Physician’s office market estimates and forecast 2018 - 2030 (USD Million)
6.5.5. Nursing Homes
6.5.5.1. Nursing homes market estimates and forecast 2018 - 2030 (USD Million)
6.5.6. Others
6.5.6.1. Others market estimates and forecast 2018 - 2030 (USD Million)
Chapter 7. Wound Care Market: Mode of Purchase Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Prescribed
7.1.2. Non-prescribed (OTC)
7.2. Mode of Purchase Market Share, 2018 & 2030
7.3. Segment Dashboard
7.4. Wound Care Market by Mode of Purchase Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
7.5.1. Prescribed
7.5.1.1. Prescribed market estimates and forecast 2018 - 2030 (USD Million)
7.5.2. Non-prescribed (OTC)
7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2018 - 2030 (USD Million)
Chapter 8. Wound Care Market: Distribution Channel Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Institutional sales
8.1.2. Retail sales
8.2. Distribution Channel Market Share, 2018 & 2030
8.3. Segment Dashboard
8.4. Wound Care Market by Distribution Channel Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
8.5.1. Institutional sales
8.5.1.1. Institutional sales market estimates and forecast 2018 - 2030 (USD Million)
8.5.2. Retail sales
8.5.2.1. Retail sales market estimates and forecast 2018 - 2030 (USD Million)
Chapter 9. Wound Care Market: Regional Estimates & Trend Analysis
9.1. Regional market share analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Application, & Forecasts and Trend Analysis, 2018 - 2030
9.5. North America
9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
9.5.2. U.S.
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. U.S. market estimates and forecasts, 2018 - 2030
9.5.3. Canada
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. Canada market estimates and forecasts, 2018 - 2030¬
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Competitive scenario
9.6.1.3. Regulatory framework
9.6.1.4. Reimbursement scenario
9.6.1.5. UK market estimates and forecasts, 2018 - 2030
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Germany market estimates and forecasts, 2018 - 2030
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Reimbursement scenario
9.6.3.5. France market estimates and forecasts, 2018 - 2030
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. Regulatory framework
9.6.4.4. Reimbursement scenario
9.6.4.5. Italy market estimates and forecasts, 2018 - 2030
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Regulatory framework
9.6.5.4. Reimbursement scenario
9.6.5.5. Spain market estimates and forecasts, 2018 - 2030
9.6.6. Denmark
9.6.6.1. Key country dynamics
9.6.6.2. Competitive scenario
9.6.6.3. Regulatory framework
9.6.6.4. Reimbursement scenario
9.6.6.5. Denmark market estimates and forecasts, 2018 - 2030
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Competitive scenario
9.6.7.3. Regulatory framework
9.6.7.4. Reimbursement scenario
9.6.7.5. Sweden market estimates and forecasts, 2018 - 2030
9.6.8. Norway
9.6.8.1. Key country dynamics
9.6.8.2. Competitive scenario
9.6.8.3. Regulatory framework
9.6.8.4. Reimbursement scenario
9.6.8.5. Norway market estimates and forecasts, 2018 - 2030
9.7. Asia Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory framework
9.7.1.4. Reimbursement scenario
9.7.1.5. Japan market estimates and forecasts, 2018 - 2030
9.7.2. India
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. India market estimates and forecasts, 2018 - 2030
9.7.3. China
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. China market estimates and forecasts, 2018 - 2030
9.7.4. South Korea
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. South Korea market estimates and forecasts, 2018 - 2030
9.7.5. Australia
9.7.5.1. Key country dynamics
9.7.5.2. Competitive scenario
9.7.5.3. Regulatory framework
9.7.5.4. Reimbursement scenario
9.7.5.5. Australia market estimates and forecasts, 2018 - 2030
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Competitive scenario
9.7.6.3. Regulatory framework
9.7.6.4. Reimbursement scenario
9.7.6.5. Thailand market estimates and forecasts, 2018 - 2030
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Competitive scenario
9.8.1.3. Regulatory framework
9.8.1.4. Reimbursement scenario
9.8.1.5. Brazil market estimates and forecasts, 2018 - 2030
9.8.2. Mexico
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory framework
9.8.2.4. Reimbursement scenario
9.8.2.5. Mexico market estimates and forecasts, 2018 - 2030
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory framework
9.8.3.4. Reimbursement scenario
9.8.3.5. Argentina market estimates and forecasts, 2018 - 2030
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Competitive scenario
9.9.1.3. Regulatory framework
9.9.1.4. Reimbursement scenario
9.9.1.5. South Africa market estimates and forecasts, 2018 - 2030
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Competitive scenario
9.9.2.3. Regulatory framework
9.9.2.4. Reimbursement scenario
9.9.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Competitive scenario
9.9.3.3. Regulatory framework
9.9.3.4. Reimbursement scenario
9.9.3.5. UAE market estimates and forecasts, 2018 - 2030
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Competitive scenario
9.9.4.3. Regulatory framework
9.9.4.4. Reimbursement scenario
9.9.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Smith & Nephew
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Mölnlycke Health Care AB
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. ConvaTec Group PLC
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Ethicon (Johnson & Johnson)
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Baxter International
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. DeRoyal Industries, Inc.
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Coloplast Corp.
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Medtronic
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. 3M
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Integra LifeSciences, Inc.
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Medline Industries, Inc.
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. B. Braun Melsungen AG
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Cardinal Health, Inc.
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Organogenesis Inc.
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. MIMEDX Group, Inc.
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings